Navigation Links
Decoy pill saves brain cells

Tricking a key enzyme can soothe over-excited receptors in the brain, say neuroscientists, calling this a possible strategy against stroke, Alzheimer's and other neurodegenerative diseases.

Lead author Michel Baudry of the University of Southern California, his graduate student Wei Xu and collaborators from the University of British Columbia outline their technique in the Feb. 1 issue of Neuron.

The researchers injected laboratory mice with a decoy peptide containing a snippet of a receptor that facilitates cell death in neurodegenerative diseases.

They hoped the toxic enzyme calpain would latch on to the decoy instead of the actual receptor, averting brain damage.

As a test, the researchers then injected the mice with kainic acid, a chemical known to cause seizures and neuron death.

While seizures still occurred, as in control mice, no brain lesions were observed in the subjects.

"We eliminate a big chunk of neuronal death," Baudry said. "I was surprised that this works. It looks like the peptide is almost completely neuroprotective."

Baudry, one of USC’s most frequently cited researchers, has been studying calpain and other chemicals in the brain for more than 20 years.

Scientists have known for decades that the neurotransmitter glutamate, which tells neurons to fire, can also destroy them. If over-activated, glutamate receptors start a chain reaction that raises the concentration of calcium and activates calpain, among other toxic enzymes.

But Baudry and Xu observed that in one receptor, mGluR1?, the situation is even worse. Under normal conditions, this receptor is neuroprotective. However, calpain truncates it and makes it neurodegenerative in such a way as to start a positive feedback loop that leads to ever-higher levels of calcium and continuous calpain activation.

In addition, by cutting mGluR1?, calpain eliminates its neuroprotective function.

The d ecoy, developed by Xu, reversed the outcomes. By tricking calpain, it prevented damage to the receptor and allowed the beneficial reaction to continue. In addition, it interrupted the feedback loop that stoked calpain activation.

"This is potentially a treatment for any conditions that involve this kind of excitotoxicity," Baudry said, and especially, he added, for the "window of opportunity" in the few hours after a stroke.

While a stroke kills some brain cells right away, others take much longer to die. If the stroke triggered a calcium-calpain feedback loop, treatment with decoy peptides might save some cells, Baudry said.

His group plans to test the treatment in a stroke model in mice.
'"/>

Source:University of Southern California


Related biology news :

1. Shark skin saves naval industry money
2. Controversial drug shown to act on brain protein to cut alcohol use
3. Mouse brain cells rapidly recover after Alzheimers plaques are cleared
4. Mouse brain tumors mimic those in human genetic disorder
5. New imaging method gives early indication if brain cancer therapy is effective, U-M study shows
6. First atlas of key brain genes could speed research on cancer, neurological diseases
7. NYU study reveals how brains immune system fights viral encephalitis
8. Stem cells from brain transformed to produce insulin at Stanford
9. Birds brains reveal source of songs
10. Loves all in the brain: fMRI study shows strong, lateralized reward, not sex, drive
11. Revolutionary nanotechnology illuminates brain cells at work

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/12/2017)...  Trovagene, Inc. (NASDAQ: TROV ), a ... that it has signed agreements with seven strategic partners ... Middle East for commercialization of the ... wave of international distribution agreements for Trovagene,s CLIA based ... The initial partners will introduce Trovagene,s liquid biopsy ...
(Date:1/11/2017)... 2017 Intoxalock, a leading ignition interlock provider, ... its patent-pending calibration device. With this new technology, Intoxalock ... upload data logs and process repairs at service center ... "Fighting drunk driving through the application of cutting-edge technologies ... but also for the customer who can get back ...
(Date:1/6/2017)... Colo. , Jan. 5, 2017  SomaLogic ... the "Digital Life Alliance" established by iCarbonX, the ... 2015 to build a "Global Digital Health Ecosystem ... on a combination of individual,s biological, behavioral and ... the agreement between the companies, SomaLogic will provide ...
Breaking Biology News(10 mins):
(Date:1/20/2017)... 20, 2017 Stock-Callers.com explores the ... influenced the most recent performances of select equities. In ... RGLS ), Abeona Therapeutics Inc. (NASDAQ: ... ), and Sage Therapeutics Inc. (NASDAQ: SAGE ... View Research, global Biotech market size is expected to reach $604.40 billion by ...
(Date:1/20/2017)... NEW YORK , January 20, 2017 ... Health Organization, cancer is one of leading causes of ... in 2012. Although the number of cancer related deaths ... since 1990. Rising in incidence rate of various cancers ... According to a research report by Global Market Insights, ...
(Date:1/19/2017)... Research and Markets has announced the addition ... Type, Application - Global Opportunity Analysis and Industry Forecast, 2014-2022" ... ... is projected to reach $15,737 million by 2022 from $6,521 in ... Omic technologies segment accounted for more than half ...
(Date:1/19/2017)... and HOUSTON , Jan. 19, ... today announced the formation of its Medical/Clinical Advisory ... and industry veterans who enhance the range and ... accelerates development of its novel prenatal diagnostic tests.  ... clinical and strategic guidance for the company,s product ...
Breaking Biology Technology: